Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Zwitter · SciRah

Researcher profile · Semantic Scholar

M. Zwitter

Share profile

M. Zwitter — researcher profile on SciRah

h-index: 19
Works: 103
Citations: 1,396

Most-cited papers

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trial.
T. Brodowicz, M. Krzakowski, M. Zwitter, V. Tzekova +16 more
2006Lung Cancer336 citations
Semantic Scholar
Factors Affecting Attitudes towards COVID-19 Vaccination: An Online Survey in Slovenia
L. Petravič, Rok Arh, Tina Gabrovec, Lucija Jazbec +7 more
2021Vaccines91 citations Open access
Semantic Scholar
Informed consent in European multicentre randomised clinical trials--are patients really informed?
C. Williams, M. Zwitter
1994European Journal of Cancer90 citations
Semantic Scholar
Communication with the cancer patient : information and truth
A. Surbone, M. Zwitter
199758 citations
Semantic Scholar
Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival
K. Stanič, M. Zwitter, N. T. Hitij, I. Kern +2 more
2014Radiology and Oncology55 citations Open access
Semantic Scholar
Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factor
U. Smrdel, M. Popović, M. Zwitter, Emanuela Boštjančič +5 more
2016Radiology and Oncology53 citations Open access
Semantic Scholar
Moral Status
M. Zwitter
2019Medical Ethics in Clinical Practice47 citations
Semantic Scholar
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma
V. Kovač, M. Zwitter, M. Rajer, A. Marin +3 more
2012Anti-Cancer Drugs38 citations
Semantic Scholar
Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial
M. Christodoulou, F. Blackhall, H. Mistry, A. Leylek +14 more
2019Journal of Thoracic Oncology35 citations Open access
Semantic Scholar
New Challenges in Communication with Cancer Patients
A. Surbone, M. Zwitter, M. Rajer, R. Stiefel
201333 citations
Semantic Scholar
Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients
V. Kovač, M. Zwitter, T. Žagar
2012Radiology and Oncology32 citations Open access
Semantic Scholar
The significance of adrenal metastases from lung carcinoma.
I. Kocijančič, K. Vidmar, M. Zwitter, M. Snoj
2003European Journal of Surgical Oncology29 citations
Semantic Scholar
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II Clinical Trial
M. Zwitter, V. Kovač, U. Smrdel, M. Vrankar +1 more
2009Journal of Thoracic Oncology26 citations Open access
Semantic Scholar
Total body irradiation with translation method.
Bogdan Umek, M. Zwitter, H. Habic
1996Radiotherapy and Oncology26 citations
Semantic Scholar
GPs facing reluctant and demanding patients: analysing ethical justifications.
S. Bremberg, T. Nilstun, Vilijem Kovac, M. Zwitter
2003Family Practice25 citations
Semantic Scholar
Ethical Theories
M. Zwitter
2019Medical Ethics in Clinical Practice24 citations
Semantic Scholar
Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations
M. Zwitter, M. Rajer, K. Stanič, M. Vrankar +5 more
2016Cancer Biology & Therapy24 citations Open access
Semantic Scholar
Two schedules of chemotherapy for patients with non-small cell lung cancer in poor performance status: a phase II randomized trial
M. Zwitter, V. Kovač, M. Rajer, M. Vrankar +1 more
2010Anti-Cancer Drugs24 citations
Semantic Scholar
PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy.
M. Vrankar, M. Zwitter, I. Kern, K. Stanič
2018Neoplasma (Bratislava)23 citations Open access
Semantic Scholar
Pollution in the working place and social status: co-factors in lung cancer carcinogenesis.
M. Rajer, M. Zwitter, B. Rajer
2014Lung Cancer16 citations
Semantic Scholar
Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations
M. Zwitter, K. Stanič, M. Rajer, I. Kern +3 more
2014Radiology and Oncology15 citations Open access
Semantic Scholar
Phase I–II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer
M. Zwitter, V. Kovač, Uros Smrdel, I. Kocijančič +2 more
2005Anti-Cancer Drugs13 citations
Semantic Scholar
Professional and public attitudes towards unsolicited medical intervention
M. Zwitter, T. Nilstun, L. Knudsen, B. Zakotnik +5 more
1999British medical journal13 citations Open access
Semantic Scholar
Cyclosporine may alleviate B symptoms and induce a remission of heavily pretreated Hodgkin disease: a preliminary report.
M. Zwitter, JOžE Drinovec, Mirko Dubravčić, Alenka Vodnik +4 more
1987Annals of Internal Medicine13 citations
Semantic Scholar
Ethics at the Beginning of Life
M. Zwitter
2019Medical Ethics in Clinical Practice12 citations
Semantic Scholar
Immunohistochemistry for EGFR Mutation Detection in Non–Small‐Cell Lung Cancer
N. T. Hitij, I. Kern, A. Sadikov, L. Knez +3 more
2017Clinical Lung Cancer12 citations
Semantic Scholar
Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial
M. Zwitter, M. Rajer, V. Kovač, I. Kern +2 more
2011Journal of Biomedicine and Biotechnology12 citations Open access
Semantic Scholar
Therapy of small cell lung cancer with emphasis on oral topotecan.
R. Pirker, P. Berzinec, S. Brincat, P. Kasan +12 more
2010Lung Cancer12 citations
Semantic Scholar
Gemcitabine and cisplatin (GC) +/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)
M. Krzakowski, M. Wenczl, T. Brodowicz, V. Tzekova +6 more
200412 citations
Semantic Scholar
Glioblastoma patients in Slovenia from 1997 to 2008
U. Smrdel, V. Kovač, M. Popović, M. Zwitter
2014Radiology and Oncology11 citations Open access
Semantic Scholar
Consensus on medical treatment of non-small cell lung cancer.
C. Zielinski, T. Beinert, J. Crawford, J. Fischer +16 more
2002Lung Cancer11 citations
Semantic Scholar
Learning from the World
A. Surbone, M. Zwitter
1997Annals of the New York Academy of Sciences11 citations
Semantic Scholar
Lung Cancer in Slovenia.
M. Zwitter, T. Čufer, M. Vrankar, I. Kern +4 more
2019Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
Dutch statistics on lung cancer: sobering experience for a new approach.
M. Zwitter
2012Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial
M. Vrankar, M. Zwitter, Tanja Bavcar, Ana Milić +1 more
2014Radiology and Oncology9 citations Open access
Semantic Scholar
Gemcitabine and cisplatin (GC) +/- subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG).
M. Krzakowski, Miklos Wenczl, T. Brodowicz, V. Tzekova +7 more
2003Journal of Clinical Oncology9 citations
Semantic Scholar
A case-control study of Hodgkin's disease and pregnancy.
M. Zwitter, M. P. Žakelj, K. Kosmelj
1996British Journal of Cancer9 citations Open access
Semantic Scholar
Gemcitabine, Cisplatin, and Hyperfractionated Accelerated Radiotherapy for Locally Advanced Non-small Cell Lung Cancer
M. Zwitter, V. Kovač, U. Smrdel, P. Strojan
2006Journal of Thoracic Oncology8 citations Open access
Semantic Scholar
A personal critique: evidence-based medicine, methodology, and ethics of randomised clinical trials.
M. Zwitter
2001Critical reviews in oncology/hematology8 citations
Semantic Scholar
Communicatin with the Patient in Clinical Research
M. Zwitter
1997Annals of the New York Academy of Sciences8 citations
Semantic Scholar
Dorothy Reed and Hodgkin's disease: a reflection after a century.
M. Zwitter, Joel R. Cohen, A. Barrett, E. D. Robinton
2002International Journal of Radiation Oncology, Biology, Physics7 citations
Semantic Scholar
On the potential role of cyclosporin in the treatment of lymphoproliferative diseases.
M. Zwitter
1988Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis7 citations
Semantic Scholar
Medical Ethics in Clinical Practice
M. Zwitter
2019Cambridge International Law Journal6 citations
Semantic Scholar
Mental Disorders after Laryngectomy
P. Strojan, M. Zwitter
2005Oncology Research and Treatment6 citations Open access
Semantic Scholar
A survey of the ethical considerations in randomised trials for lung cancer.
M. Zwitter, J. Tobias
1998Lung Cancer6 citations
Semantic Scholar
Toxicity and quality of life in published clinical trials for advanced lung cancer
M. Zwitter
2018Supportive Care in Cancer5 citations
Semantic Scholar
Metastatic adenocarcinoma of the lung in a 27-year-old pregnant woman.
J. Hadžić, A. Secerov, M. Zwitter, J. Lamovec +4 more
2007Journal of Thoracic Oncology5 citations Open access
Semantic Scholar
Informed consent in european multicentric randomised clinical trials
M. Zwitter, CJ Williams
19935 citations
Semantic Scholar
Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily Versus Twice-Daily Radiotherapy (CONVERT) Trial.
M. Christodoulou, F. Blackhall, H. Mistry, A. Leylek +14 more
20174 citations Open access
Semantic Scholar
Combining cytotoxic and targeted therapies for lung cancer.
M. Zwitter
2010Journal of Thoracic Oncology4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Kovač×12
Invite
V. Kovač — researcher profile on SciRah
M. Vrankar×10
Invite
M. Vrankar — researcher profile on SciRah
I. Kern×8
Invite
I. Kern — researcher profile on SciRah
U. Smrdel×7
Invite
U. Smrdel — researcher profile on SciRah

×7

Invite

M. Rajer — researcher profile on SciRah

C. Zielinski×5

Invite

C. Zielinski — researcher profile on SciRah

Invite

K. Stanič — researcher profile on SciRah

Invite

V. Tzekova — researcher profile on SciRah

T. Brodowicz×3

Invite

T. Brodowicz — researcher profile on SciRah

M. Krzakowski×3

Invite

M. Krzakowski — researcher profile on SciRah

Invite

R. Ramlau — researcher profile on SciRah

Invite

A. Surbone — researcher profile on SciRah